Music Matters
How Chord Inversions Work - Music Theory
Learn how chord inversions work, what they are, how and when to use them, and how to label them. This music theory lesson includes U.K. and U.S. terminology to describe inversion chords and you will learn how to use all the diatonic...
Cerebellum
French: Aller (To Go) and Faire (To Do)
This clip provides a deeper dive into two important French verbs: Aller (To Go) and Faire (To Do). This is part 3 in the series: 'French: Asking About The Weather'.
Music Matters
Extended Chords Made Clear - Music Theory
Always wondered what we mean by the term extended chords? Want to use extended chords but not sure how to? Are you a composer who can use chords but want your chords to be more interesting and more colourful? Want to be able to use...
Two Minute Music Theory
Building Chords: Chord Inversions - TWO MINUTE MUSIC THEORY #42
Season 3, Episode 22 - Two Minute Music Theory The third installment in our Building Chords Series. Today we look at what happens when the chord isn't stacked like it normally is. When notes aren't in their normal position, we call that...
Two Minute Music Theory
FAQ #2: How Do I Better Hear Intervals?
I've gotten a lot of questions over the last 5 years. Some of them more than others, so today I'm starting an FAQ series. Today, we'll look at how to listen for the intervals and hear them better.
Bloomberg
No New Economic Policy in Obama Speech: Furman
Oct. 2 -- Council of Economic Advisers Chairman Jason Furman previews President Obamas speech on the economy. He speaks with Peter Cook on Money Clip. (Source: Bloomberg)
Bloomberg
Yield Curve Inversion, U.S. Stocks, BOJ: 3-Minute MLIV
Mark Cudmore and Anna Edwards break down today's key themes for analysts and investors on "Bloomberg Markets Europe." For up to the minute market intelligence and insight, click MLIV .
Bloomberg
Why Warren Buffett Loves Duracell: Tax Savings
Nov. 13 -- Bloomberg View Columnist Gary Shilling, Sonenshine Partners Chairman Marshall Sonenshine and Bloomberg's Jeff McCracken discuss Berkshire Hathaways purchase of Duracell and the tax implications of the deal. They speak on...
Bloomberg
Is Tax Inversion Rule-Tightening Ahead?
Aug. 12 -- Tax inversions are back in the news after Donald Trump renewed his criticism of the financial maneuver earlier this week. But what is being done to prevent U.S. companies from shifting their legal addresses abroad to lower...
Bloomberg
The Tax Inversion Deal Crackdown
Sept. 25 -- Bloomberg Intelligence Senior Pharmaceutical Analyst Sam Fazeli discusses tax inversion on Bloomberg Surveillance. (Source: Bloomberg)
Bloomberg
QuickTake: How U.S. Companies Buy Tax Breaks
April 11 -- Bloomberg's Scarlet Fu reports on today's top news "QuickTake". She speaks on "Bloomberg Markets."
Bloomberg
Pfizer Looks Outside U.S. Despite New Tax Rules
Sept. 24 -- Bloomberg's Hans Nichols reports on the U.S. governments attempts to curb corporate tax inversions. He speaks on Bloomberg Televisions On The Move. (Source: Bloomberg)
Bloomberg
Heres the Downside to Treasurys Inversion Curbs
Sept. 23 -- Nancy McLernon, Chief Executive Officer at Organization for International Investment, examines steps taken by the U.S. Treasury to curb tax inversion deals and explains how the country would be better served by tackling...
Curated Video
Allergan, Pfizer Call Off Proposed $160B Merger
FOR CLEAN VERSION SEE STORY NUMBER: apus052600The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to...
Bloomberg
Is Pfizer-Allergan the End of Tax Inversion Deals?
April 6 -- Pfizer Inc. and Allergan agreed to end their $160 billion merger agreement following U.S. government action on tax inversions. Bloomberg's Matt Campbell examines where the two companies go from here and how the end of the...
Bloomberg
Pfizer Said to Have Approached Actavis About Deal
Sept. 24 -- Bloomberg's Hans Nichols reports on Pfizer approaching Actavis to express interest in an acquisition. He speaks to Mark Barton on ""Countdown."" (Source: Bloomberg)
Bloomberg
Markets See Risk Around Pfizer-Allergan Merger Deal
April 5 - A potential $160 billion merger between Pfizer and Allergan may be put in jeopardy by new steps taken by the U.S. government to limit tax-cutting in corporate inversions. Bloomberg's Zach Mider explains on "Bloomberg ‹GO›."
Bloomberg
Bull Market Still Mid-Cycle, Fed Cuts Will End Yield Inversion: Baird
Aug.15 -- Patrick Spencer, Baird vice chairman of equities, discusses investment strategy and the outlook for the bond and equity markets on "Bloomberg Markets: European Close."
Amoeba Sisters
Mutations: The Potential Power of a Small Change
Are the only mutants you know Ninja Turtles or X-Men? The video explains both gene mutation and chromosome mutation. It includes the subtypes of mutations for each major type, the times when mutations are more likely to happen, and...